276 related articles for article (PubMed ID: 21537047)
1. Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
Fusco V; Galassi C; Berruti A; Ciuffreda L; Ortega C; Ciccone G; Angeli A; Bertetto O
J Clin Oncol; 2011 Jun; 29(17):e521-2; author reply e523-4. PubMed ID: 21537047
[No Abstract] [Full Text] [Related]
2. More about osteonecrosis.
Finkelman RD; Clemons M; Bouganim N
J Am Dent Assoc; 2011 Apr; 142(4):371-2; author reply 372-4. PubMed ID: 21454842
[No Abstract] [Full Text] [Related]
3. Osteonecrosis of the jaw.
Drozdzowska B
Endokrynol Pol; 2011; 62(1):88-92. PubMed ID: 21365586
[TBL] [Abstract][Full Text] [Related]
4. Denosumab-related osteonecrosis of the jaws.
Kyrgidis A; Toulis KA
Osteoporos Int; 2011 Jan; 22(1):369-70. PubMed ID: 20306021
[No Abstract] [Full Text] [Related]
5. Denosumab for bone metastases from breast cancer: a new therapy option?
Aapro MS
J Clin Oncol; 2011 May; 29(14):e419-20; author reply e421-4. PubMed ID: 21464408
[No Abstract] [Full Text] [Related]
6. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the jaw and the role of macrophages.
Pazianas M
J Natl Cancer Inst; 2011 Feb; 103(3):232-40. PubMed ID: 21189409
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and osteonecrosis of the jaw: a case report.
Reiriz AB; De Zorzi Pde M; Lovat CP
Clinics (Sao Paulo); 2008 Apr; 63(2):281-4. PubMed ID: 18438586
[No Abstract] [Full Text] [Related]
9. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.
Fizazi K; Carducci M; Smith M; Damião R; Brown J; Karsh L; Milecki P; Shore N; Rader M; Wang H; Jiang Q; Tadros S; Dansey R; Goessl C
Lancet; 2011 Mar; 377(9768):813-22. PubMed ID: 21353695
[TBL] [Abstract][Full Text] [Related]
10. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
Smith A; Kressley A; Saif MW
JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
[No Abstract] [Full Text] [Related]
11. Denosumab an option for patients with bone metastasis from breast cancer.
Barton MK
CA Cancer J Clin; 2011; 61(3):135-6. PubMed ID: 21532096
[No Abstract] [Full Text] [Related]
12. A new class of drugs to prevent osteoporosis may be associated with osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2011; 59(1):10-2. PubMed ID: 21613033
[No Abstract] [Full Text] [Related]
13. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
Jimenez-Soriano Y; Bagan JV
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
[No Abstract] [Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
Longo R; Castellana MA; Gasparini G
J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
[No Abstract] [Full Text] [Related]
15. Safety of denosumab in giant-cell tumour of bone.
Thomas D; Carriere P; Jacobs I
Lancet Oncol; 2010 Sep; 11(9):815. PubMed ID: 20816372
[No Abstract] [Full Text] [Related]
16. Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concern.
Aguiar Bujanda D; Cabrera Suárez MA; Bohn Sarmiento U; Quintero Pérez S; Aguiar Morales J
Clin Transl Oncol; 2006 Dec; 8(12):919-21. PubMed ID: 17169767
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the jaw.
Sari E; Bulut N; Altundag K
J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
[No Abstract] [Full Text] [Related]
18. [Avascular osteonecrosis of the jaws induced by diphosphonates].
Lannoy D; Decaudin B; Barrier F; Bemba M; Wierre L; Pignon JM; Horrent S; Résibois JP; Wetterwald M; Odou P
Therapie; 2006; 61(4):363-5. PubMed ID: 17124954
[No Abstract] [Full Text] [Related]
19. Antiresorptive drug-related osteonecrosis of the jaw.
Uyanne J; Calhoun CC; Le AD
Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients after Treatment with Zoledronic Acid or Denosumab: A Retrospective Cohort Study.
Kajizono M; Sada H; Sugiura Y; Soga Y; Kitamura Y; Matsuoka J; Sendo T
Biol Pharm Bull; 2015; 38(12):1850-5. PubMed ID: 26632176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
